Literature DB >> 16915106

Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study.

Marc Auburtin1, Michel Wolff, Julien Charpentier, Emmanuelle Varon, Yves Le Tulzo, Christophe Girault, Ismaël Mohammedi, Benoît Renard, Bruno Mourvillier, Fabrice Bruneel, Jean-Damien Ricard, Jean-François Timsit.   

Abstract

OBJECTIVE: To identify factors associated with mortality and morbidity among adults admitted to intensive care units (ICUs) for pneumococcal meningitis, particularly the impact of delayed antibiotic administration.
DESIGN: We conducted a prospective, multicenter, observational study of 156 consecutive adults hospitalized for pneumococcal meningitis. We analyzed parameters associated with 3-month survival.
SETTING: Fifty-six medical and medical-surgical ICUs in France. INTERVENTION: None.
RESULTS: Of the 148 strains isolated, 56 (38%) were nonsusceptible to penicillin G. At 3 months after ICU admission, the mortality rate was 33% (51/156), and 34% of survivors (36/105) had neurologic sequelae. Multivariate analysis identified three variables as independently associated with 3-month mortality: Simplified Acute Physiology Score II (odds ration [OR], 1.12; 95% confidence interval [CI], 1.072-1.153; p = .002); isolation of a nonsusceptible strain (OR, 6.83; 95% CI, 2.94-20.8; p < 10(-4)), and an interval of >3 hrs between hospital admission and administration of antibiotics (OR, 14.12; 95% CI, 3.93-50.9; p < 10(-4)). In contrast, a cerebrospinal fluid leukocyte count >10(3) cells/microL had a protective effect (OR, 0.30; 95% CI, 0.10-0.944; p = 0.04).
CONCLUSIONS: Independent of severity at the time of ICU admission, isolation of penicillin-nonsusceptible strains and a delay in antibiotic treatment following admission were predictors of mortality among patients with pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915106     DOI: 10.1097/01.CCM.0000239434.26669.65

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  54 in total

1.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Understanding coma in bacterial meningitis.

Authors:  R Sonneville; G Citerio; G Meyfroidt
Journal:  Intensive Care Med       Date:  2015-09-28       Impact factor: 17.440

3.  CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.

Authors:  S Giulieri; C Chapuis-Taillard; K Jaton; A Cometta; C Chuard; O Hugli; R Du Pasquier; J Bille; P Meylan; O Manuel; O Marchetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-19       Impact factor: 3.267

4.  [Door-to-Action-Time].

Authors:  Wilfred Druml; Michael Hiesmayr
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  Prognostic factors in adult community-acquired bacterial meningitis: a 4-year retrospective study.

Authors:  F A Dauchy; D Gruson; G Chêne; J Viot; C Bebear; J Maugein; M C Bézian; H Dutronc; M Dupon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

6.  Bacterial meningitis complicating the course of liver cirrhosis.

Authors:  Pasquale Pagliano; Giovanni Boccia; Francesco De Caro; Silvano Esposito
Journal:  Infection       Date:  2017-06-14       Impact factor: 3.553

7.  Case Report: Disseminated Shewanella algae Infection with Meningoencephalitis in a Traveler Secondary to Marine Injury in Madagascar.

Authors:  Caroline Brulliard; Nicolas Traversier; Jérôme Allyn; Christopher Schaeffer; Bruno Bouchet; Nicolas Allou
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 8.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  [Severe pneumococcal infections in the elderly - preventable by vaccination].

Authors:  H Hof; A Fahr; M Holfelder; R Schwarz; K Oberdorfer
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

10.  Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study.

Authors:  Jean-Pierre Bedos; Emmanuelle Varon; Raphael Porcher; Pierre Asfar; Yves Le Tulzo; Bruno Megarbane; Armelle Mathonnet; Anthony Dugard; Anne Veinstein; Kader Ouchenir; Shidasp Siami; Jean Reignier; Arnaud Galbois; Joël Cousson; Sébastien Preau; Olivier Baldesi; Jean-Philippe Rigaud; Bertrand Souweine; Benoit Misset; Frederic Jacobs; Florent Dewavrin; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2018-11-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.